Canara HSBC Life Insurance Company Limited, a leading private life insurer jointly promoted by Canara Bank and HSBC Insurance (Asia-Pacific) Holdings Limited, has launched its ₹2,517.50 crore Initial Public Offering (IPO), entirely as an Offer for Sale (OFS) (i.e., no fresh capital is being raised). The IPO opened for subscription on October 10, 2025, with a price band set between ₹100 and ₹106 per share. The subscription window will close on October 14, 2025, and the shares are scheduled to be listed on both the BSE and NSE on October 17, 2025.
Canara HSBC Life Insurance IPO Day 3 Subscription Status
On Day 3, the Canara HSBC Life Insurance Company IPO received a moderate response from investors, closing with an overall subscription of 2.05 times. The Qualified Institutional Buyers (QIB) category led the demand with a subscription of 7.05 times, indicating strong interest from institutional investors. The Non-Institutional Investors (NII) segment recorded a subscription of 0.33 times, showing limited participation from high-net-worth investors. Within this segment, the bNII (above ₹10 lakh) portion was subscribed 0.28 times, while the sNII (less than ₹10 lakh) portion saw a subscription of 0.44 times. The Retail Individual Investors (RII) category recorded a subscription of 0.42 times, reflecting a modest response from retail participants.
Investor Category
Subscription (x)
Qualified Institutional Buyers (QIB)
7.05
Non-Institutional Investors (NII)
0.33
bNII (above ₹10 lakh)
0.28
sNII (less than ₹10 lakh)
0.44
Retail Individual Investors (RII)
0.42
Total Subscriptions
2.05
Total Applications: 1,74,847
Total Bid Amount (₹ Crores): 4,055
How to Check Canara HSBC Life Insurance Co.Ltd IPO Allotment Status
Canara HSBC Life Insurance allotment can be easily checked online in two ways: from the Registrar’s website and from the BSE or NSE website. This IPO will be listed on both the exchanges – BSE and NSE, so the allotment status will be available to all investors on both platforms.
Select “Canara HSBC Life Insurance ” from the IPO list
Enter PAN number and Application number
Click on Search
Objective of the Canara HSBC Life Insurance
Canara HSBC Life Insurance will not receive any proceeds from the Offer. All funds raised through the Offer will go entirely to the Selling Shareholder, after deduction of Offer-related expenses and applicable taxes, which will be borne solely by the Selling Shareholder.
Canara HSBC Life Insurance GMP – Day 3 Update
The grey market premium (GMP) of Canara HSBC Life Insurance Company Limited IPO stood at ₹0 as of 5:00 PM on October 14, 2025 (Day 3). Considering the upper end of the price band at ₹106, the estimated listing price is around ₹106, indicating no gain (0%) per share.
Date
GMP
Est. Listing Price
Gain
14-10-2025 (Day 3)
₹
₹106
0%
Disclaimer: The above GMP (Grey Market Premium) is just unofficial market information, which is not officially confirmed. These figures are shared for informational purposes only and investment decisions based on these should be based on the investor’s own research and discretion. We do not conduct, recommend or support any kind of transaction in the grey market.
Canara HSBC Life Insurance – Key Details
Particulars
Details
IPO Opening Date
October 10, 2025
IPO Closing Date
October 14, 2025
Issue Price Band
₹100 to ₹106 per share
Total Issue Size
23,75,00,000 shares(aggregating up to ₹2,517.50 Cr)
Important Dates for Canara HSBC Life Insurance Allotment
Event
Date
Tentative Allotment
October 15, 2025
Refunds Initiation
October 16, 2025
Credit of Shares to Demat
October 16, 2025
Listing Date
October 17, 2025
Canara HSBC Life Insurance Overview
Canara HSBC Life Insurance, established in 2007, is a leading private life insurer in India jointly promoted by Canara Bank, the country’s fourth-largest public sector bank, and HSBC Insurance (Asia-Pacific) Holdings Limited. According to the CRISIL Report, the company ranks third among public sector bank-led life insurers in terms of lives covered and recorded the third-highest weighted premium income growth among bank-led insurers between Fiscal 2022 and 2025.
As of June 30, 2025, it managed assets of ₹61,107.40 million and maintained a strong solvency ratio of 200.42%, exceeding the 150% regulatory requirement. Profit after tax grew at a CAGR of 13.26%, reaching ₹1,169.81 million in Fiscal 2025. The company’s extensive bancassurance network, including Canara Bank, HSBC India, and regional rural banks, contributed over 90% of new business premiums in Fiscal 2025.
Canara HSBC Life offers 20 individual and 7 group products across savings, protection, retirement, and ULIP categories. Emphasizing digital transformation, 99.7% of applications were processed digitally, improving persistency and customer satisfaction. Recognized for innovation, it has received industry awards for technology and data analytics excellence. With strong promoters, sound financials, and customer-centric digital initiatives, the company continues to strengthen its leadership in India’s life insurance sector.
Frequently Asked Questions (FAQs)
What is the opening and closing date of Canara HSBC Life Insurance?
Canara HSBC Life Insurance is open on 10 October 2025 and will close on 14 October 2025.
What is the price band of the Canara HSBC Life Insurance?
Its price band is fixed from ₹100 to ₹106 per share.
What is the GMP (Grey Market Premium) of Canara HSBC Life Insurance today?
The GMP on 14 October 2025 is ₹0, which leads to a possible listing price of ₹106.
What is the total issue size of Canara HSBC Life Insurance?
The total issue size of the Canara HSBC Life Insurance is ₹2517.50 crore, entirely as an “Offer for Sale”.
What is the expected listing date of Canara HSBC Life Insurance ?
This IPO is expected to be listed on BSE and NSE on 17 October 2025.
The mutual fund market in India is growing by the day. Today, thematic mutual funds in India offer a new opportunity for investors who invest not just in companies but in larger trends, such as Digital India, the energy transition, or the defense industry. They are on the verge of becoming the top-ranked mutual funds in India by 2025. In this blog, we’ll explore how thematic funds work, where they rank among mutual funds in India, and how you can choose your own top-rated mutual fund schemes/SIPs.
What are Thematic Mutual Funds?
Thematic mutual funds are funds that invest based on a specific theme or idea. This theme can encompass more than one sector. For example, a “Digital India” theme might include IT, telecom, and fintech companies.
How do they work?
These funds typically employ a top-down investment approach. The fund manager first determines which themes (such as defense, energy transition, electric vehicles) will be strong over the long term. Then, investments are made in various sectors and companies aligned with that theme. This way, investors become participants in the entire trend, not just a single sector.
List of Best Thematic Mutual Funds in India 2025
S.No
Fund Name
AUM (Rs Cr)
3 / 5 Years Return (%)
3 / 5 Years Category Average
Current NAV
1
ICICI Prudential Technology Fund
₹14,734Cr
14.85% / 18.55%
19.55% / 22.326%
₹190.58
2
Mirae Asset Great Consumer Fund
₹4,552Cr
17.13% / 21.80%
19.55% / 22.32%
₹94.97
3
ICICI Prudential Manufacturing Fund
₹6,490Cr
26.82 % / 28.84%
19.29 % / 22.23%
₹35.26
4
Sundaram Services Fund
₹4,333Cr
18.36% / 24.21%
19.71% / 23.99%
₹34.46
5
UTI-Transportation and Logistics Fund
₹3,741Cr
24.59% / 26.84%
19.29% / 23.28%
₹290.60
6
SBI Consumption Opportunities Fund
₹3,175Cr
14.59% / 24.31%
19.17% / 22.47%
₹306.53
7
HDFC Housing Opportunities Fund
₹1,285Cr
19.73% / 23.80%
19.29% / 23.28%
₹22.03
8
Aditya Birla Sun Life Manufacturing Equity Fund
₹1043Cr
18.65% / 18.32%
19.29% / 23.28%
₹32.05
9
Edelweiss Recently Listed IPO Fund
₹924Cr
15.61% / 19.77%
18.29% / 22.28%
₹27.14
10
SBI Comma Fund
₹702Cr
16.47% / 20.44%
19.29% / 22.44%
₹104.28
(Data as of 26 Sep 2025)
A brief overview of the Best Thematic Mutual Funds in India 2025 are given below:
1. ICICI Prudential Technology Fund
This fund is managed by ICICI Prudential AMC and primarily invests in IT sector and technology-related stocks. It was launched on June 22, 1993, and today is considered one of India’s leading technology-focused mutual funds. The fund’s objective is to provide investors with long-term exposure to the growth of the technology sector. It is currently managed by Vaibhav Dusad. The fund’s portfolio is concentrated in large IT giants such as Infosys, TCS, Wipro, and Tech Mahindra, providing it with strong stability and sector-specific exposure.
Fund details :
Min SIP
Min Investment
Fund Manager
₹100
₹5,000
Vaibhav Dusad
2. Mirae Asset Great Consumer Fund
Mirae Asset Great Consumer Fund is a thematic equity fund managed by Mirae Asset Mutual Fund. It aims to enable investors to participate in India’s consumption growth story. As the middle class and income levels in the country are growing, demand for consumer-based companies is also steadily increasing. The fund focuses on industries such as FMCG, automobile, telecom, and retail. The portfolio consists of a mix of large and reliable companies. ITC, Hindustan Unilever, and Asian Paints represent FMCG and branded consumer goods. Mahindra & Mahindra and Maruti Suzuki provide exposure to the automobile segment. Bharti Airtel captures the growth of the telecom sector, while Trent and Avenue Supermarts focus on retail and consumer services. Eicher Motors and Eternal Ltd. further diversify the portfolio.
Fund details :
Min SIP
Min Investment
Fund Manager
₹1000
₹5,000
Siddhant Chhabria
3. ICICI Prudential Manufacturing Fund
This fund is managed by ICICI Prudential AMC and focuses on India’s manufacturing sector. It aims to invest in companies that are directly linked to the country’s industrial progress and the “Make in India” initiative. The fund is currently managed by Antariksh Banerjee and is designed to capture the benefits of long-term manufacturing growth.
Its portfolio includes large and strong industries. Giants like Ultratech Cement and Ambuja Cements represent India’s manufacturing sector. Mahindra & Mahindra and Hindustan Aeronautics capture the growth story of automobiles and aerospace. Names like Cummins India and JSW Steel reflect the strength of the industrial machinery and metals sectors.
Fund details :
Min SIP
Min Investment
Fund Manager
₹100
₹5,000
Antariksha Banerjee
4. Sundaram Services Fund
Sundaram Services Fund is a thematic mutual fund managed by Sundaram Mutual Fund. Its objective is to invest in Indian services-based companies, as the service sector continues to grow in India’s economy. The fund was launched on February 26, 1996, and is currently managed by Rohit Seksaria. The fund’s portfolio focuses on leading service-based companies. Major companies like Bharti Airtel and Reliance Industries represent telecom and consumer services, while HDFC Bank and Axis Bank represent financial services strengths. Additionally, exposure to Tri-Party Repo (TREPS) helps manage liquidity. This mix provides a balanced and diversified perspective on the services sector.
Fund details :
Min SIP
Min Investment
Fund Manager
₹100
₹100
Rohit Seksaria
5. UTI-Transportation and Logistics Fund
UTI-Transportation and Logistics Fund is a sector-specific thematic fund managed by UTI Mutual Fund. The fund was launched on November 14, 2002, and is currently managed by Sachin Trivedi. Its objective is to benefit investors from the growth of India’s automobile, logistics, and transportation sectors. The portfolio includes key companies representing the auto and transportation sectors. Mahindra & Mahindra and Maruti Suzuki cover India’s passenger and utility vehicle segments. Eicher Motors and Bajaj Auto demonstrate strength in two-wheelers and commercial vehicles. Interglobe Aviation (IndiGo) provides air traffic exposure, while Eternal Ltd. further diversifies the portfolio.
Fund details :
Min SIP
Min Investment
Fund Manager
₹500
₹5,000
Sachin Trivedi
6. SBI Consumption Opportunities Fund
SBI Consumption Opportunities Fund is a thematic equity fund managed by SBI Mutual Fund. It was launched on February 7, 1992, and is currently managed by Ashit Desai. The fund aims to capture the story of India’s growing consumption sector. As income levels and consumer demand rise, the prospects for consumption-based companies are also brightening. Its portfolio includes leading consumption companies. Bharti Airtel represents telecom consumption, while Jubilant FoodWorks and Britannia Industries cover the Indian food and FMCG segments. Major companies like Hindustan Unilever and Asian Paints represent premium consumer brands. Mahindra & Mahindra provides strong exposure to automobile consumption.
Fund details :
Min SIP
Min Investment
Fund Manager
₹500
₹5,000
Ashit Desai
7. HDFC Housing Opportunities Fund
HDFC Housing Opportunities Fund is a thematic equity fund managed by HDFC Mutual Fund. Launched on December 10, 1999, the fund is currently managed by Srinivasan Ramamurthy. Its objective is to capture opportunities in India’s housing and infrastructure sectors. Given the country’s urbanization and growing housing demand, this theme is considered relevant for the long term. The fund’s portfolio focuses on large financial institutions and infrastructure companies. These include major financial institutions like HDFC Bank and ICICI Bank, which are involved in housing finance and retail loan growth. Larsen & Toubro and Ambuja Cements represent the strength of the construction and cement sectors. NTPC, the backbone of energy supply, and State Bank of India, as the country’s largest bank, provide further balance to this theme.
Fund details :
Min SIP
Min Investment
Fund Manager
₹100
₹100
Srinivasan Ramamurthy
8. Aditya Birla Sun Life Manufacturing Equity Fund
Aditya Birla Sun Life Manufacturing Equity Fund is a thematic fund managed by Aditya Birla Sun Life AMC. It was launched on September 5, 1994, and is currently managed by Harsh Krishnan. The fund focuses on opportunities in India’s manufacturing sector and invests in companies directly involved in industrial production, automobiles, engineering, and basic industries. The fund’s portfolio includes several prominent and trusted names. Reliance Industries is a leading player in diversified manufacturing and energy. Hindalco Industries is a leader in metals and aluminum manufacturing. Maruti Suzuki and Mahindra & Mahindra demonstrate strong presence in automobile manufacturing. Cummins India provides exposure to industrial machinery and engineering, while United Breweries contributes to consumer and beverage manufacturing.
Fund details :
Min SIP
Min Investment
Fund Manager
₹1000
₹1,000
Harsh Krishnan
9. Edelweiss Recently Listed IPO Fund
The Edelweiss Recently Listed IPO Fund is a unique thematic fund managed by Edelweiss Mutual Fund. It was launched on August 23, 2007, and is currently managed by Bhavesh Jain. The fund invests in companies that have recently listed through an IPO (Initial Public Offering). Its objective is to enable investors to participate in the early growth story of newly listed businesses. The fund’s portfolio focuses on new and emerging businesses across diverse sectors. It includes consumer and automobile brands such as Hyundai Motor India and Vishal Mega Mart. Swiggy reflects the strength of the digital consumption and food delivery sectors. Bajaj Housing Finance provides exposure to financial services, and Sai Life Sciences and Sagility Ltd. represent growth in the healthcare and research sectors.
Fund details :
Min SIP
Min Investment
Fund Manager
₹500
₹5000
Bhavesh Jain
10. SBI Comma Fund
SBI Comma Fund is a thematic equity fund managed by SBI Mutual Fund. It was launched on February 7, 1992, and is currently managed by Dinesh Balachandran. The fund primarily invests in the commodities, materials, and energy sectors. These sectors, linked to India’s industrial and energy needs, have long been considered the backbone of economic growth, and this is the fund’s primary focus. The portfolio includes leading commodity and energy companies. Tata Steel and Vedanta provide exposure to metals and mining. Reliance Industries represents the energy and petrochemical sectors. Ultratech Cement covers construction and infrastructure growth, while ONGC is a major player in oil and gas production. CESC Ltd. also provides stability to the power supply and utilities sectors.
Policy Support : The Indian government has paid special attention to sectors such as defense, infrastructure, energy transition, and the digital economy in recent years. Policy support in these sectors can provide thematic funds with the opportunity for long-term, stable growth.
Benefiting from Changing Economic Trends : Trends such as digital transactions, electric vehicles, healthcare, and renewable energy will strengthen in the coming years. Thematic mutual funds offer investors the opportunity to participate in these changes from an early stage.
Potential for Additional Returns : When the chosen theme remains relevant over the long term, thematic funds have the potential to deliver better returns than traditional diversified equity funds. However, this is not always guaranteed and involves higher risk.
A Different Approach from Sectoral Funds : Sectoral funds focus on a single industry, while thematic funds invest in multiple industries within a larger story. This helps spread the risk somewhat.
Growing Investor Interest : Investor interest in thematic funds has increased over the past few years. This is because investors prefer to invest in sectors and trends that have strong future potential.
Potential to Outperform Indices : Over some periods, thematic funds have outperformed broad indices. However, their performance depends on trends and market conditions, so investors should have realistic expectations.
Strategic Role in Portfolios : These funds are best held as satellite allocations rather than as part of a core portfolio. This allows investors to take advantage of emerging trends while maintaining portfolio diversification.
Emerging Investment Themes in India 2025
Defense and Aerospace : The country is moving towards becoming self-reliant in defense equipment. Continued large orders and export opportunities are strengthening this theme.
Infrastructure and PSUs : Government spending on roads, railways, and power is steadily increasing. This is benefiting not only infrastructure companies but also many public sector undertakings.
Energy Transition : In keeping with climate goals, there is a significant emphasis on renewable energy. Solar, wind, and battery technology are at the center of this transition.
Electric Vehicles and Electronics : EV adoption is increasing, and domestic electronics manufacturing is also strengthening. Battery and charging networks are driving this trend.
Digital and Fintech : Digital payments and online services have become a daily necessity. Investment in data security and cloud services will also increase in the coming years.
Healthcare and Pharma : Growing demand for healthcare and the discovery of new medicines are continuously strengthening this sector.
Premium Consumption : As incomes rise, people are increasingly investing in premium and branded products. This theme is expected to deepen in the coming years.
Thematic mutual funds are attractive, but they carry some significant risks that should not be overlooked.
Relying solely on the theme : People often invest under the influence of a story or trend. However, not every theme succeeds. The true strength comes from the companies’ earnings and business models.
Limited Diversification : Like sectoral funds, thematic funds operate within a limited range. If the theme weakens, the entire portfolio can be affected.
Liquidity Issues : Some themes are based on small stocks. These stocks cannot be easily sold during difficult times, which can increase losses.
The Importance of Timing : Timely entry and exit are crucial in these funds. Late entry or hasty exit can impact returns.
Investor Behavior : FOMO in a bull market and panic in a bear market – this is the biggest mistake. Repeated decisions like this can weaken actual returns.
Taxation of Thematic Funds in India (2025 Update)
Equity-oriented Thematic Funds Tax Rates
Short-Term Capital Gains (STCG) : If you sell equity-invested units within 12 months or less, the STCG tax rate will be 20%.
Long-Term Capital Gains (LTCG) : If the holding period is more than 12 months, the LTCG tax rate will be 12.5%.
Exemption : The first LTCG up to ₹1.25 lakh is tax-free. That is, if your LTCG is less than ₹1.25 lakh, no tax will be payable.
Thematic mutual funds offer investors the opportunity to participate in India’s rapidly changing economy and emerging trends. Whether it’s manufacturing, consumption, infrastructure, or technology, each theme offers long-term potential. However, it’s also true that they carry relatively higher risks. Therefore, it’s always wise to include them in your portfolio with a limited allocation and a long-term view.
S.NO.
Check Out These Interesting Posts You Might Enjoy!
Let’s look at a different aspect of the financial market except from buying and selling shares, this is mutual funds and dividends. So, have you ever wondered if you get extra cash back from your mutual fund investments? Many people think of this as a ‘dividend’ just like a small bonus for investing.
But have you ever wondered, do mutual funds pay dividends? The answer is yes, but it’s not exactly what you might think. It’s not really “extra” money that you get, so understanding what happens to dividends in mutual funds is one of the most important things for an investor.
In this blog we will look upon how mutual funds pay dividends to the investors.
What’s a Mutual Fund Dividend?
A mutual fund is like a big investment basket managed by a registered & professional fund manager. This basket makes money in a few ways:
Company Profits: If your fund owns shares of a company like TCS, and TCS decides to share its profits, your fund gets a piece of that.
Interest Earnings: If your fund has lent money (by buying bonds), it earns interest, just like a bank FD.
Smart Selling: When the fund manager sells an investment for more than they paid, the fund makes a profit.
All this money gets collected in the fund. After paying its running costs, the leftover profit can be shared with you.
Here’s something every investor in India needs to know. In 2021, the market regulator and watchdog SEBI changed the name of the “Dividend Option” to IDCW which stands for Income Distribution cum Capital Withdrawal.
SEBI wanted to be crystal clear and protect the investors from being misled. The old name, “dividend,” made it sound like you were getting extra bonus money from your investments but this was not the whole story.
Income Distribution: This is the part that comes from the fund’s actual earnings.
cum Capital Withdrawal: It means some of the money you’re getting is your own invested money being handed back to you.
By this you can understand that IDWC isn’t a bonus just like a dividend. It’s the fund giving you a mix of its profits and a little bit of your own money back.
How do mutual funds pay dividends?
The fund gathers up all the profits it has made.
The fund manager looks at the pile of profits and decides if there’s enough to share.
If it’s a “yes,” the money is sent straight to your bank account. By law, it has to get to you within seven working days.
When you invest in mutual funds, you get to choose a path for your profits.
IDCW Payout: Investors can get their cash directly and it lands in your linked bank account. This is best suitable for people who need a regular stream of money, like retirees.
IDCW Reinvestment: Instead of cash, the money is used to buy you more units in the fund. Here the investor does not cash out the profits rather get more funds in it.
Growth Option: This is the most popular choice as, no money is paid out, all the profits are ploughed back into the fund to help it grow bigger and faster making it more profitable and valuable over time.
Feature
IDCW (Dividend) Plan
Growth Plan
Profits
You either get cash or more units.
Money is put back into the fund to grow.
Price
Price of the units drop after the payout
Price of unit grows over time
Units
Stays the same or gets reinvested
Stays the same
Best suitable for
Someone who needs cash in hand regularly.
Someone who wants money to grow over the years.
Taxation
You pay tax on it in the year you receive it.
You only pay tax when you decide to sell your units
How are Dividend Pay Decided?
The dividends in mutual funds are not 100% guaranteed, it’s not like a fixed deposit where you know exactly what returns you will be getting.
The fund manager is the one who takes the decision after considering the following:
Profit Generated: A fund can only be distributed if there is enough profit generated.
Market Conditions: If the market is volatile and uncertain, then the manager might decide to hold onto the cash to be safe.
Fund Basket: A fund that invests in big, steady companies might pay dividends more often than a fund that invests in exciting new startups.
How Dividends Affect Your Investment’s Value
When a fund pays you a dividend, the Net Asset Value (NAV) of your units drops by that exact amount. The NAV is just the price tag on one unit of your fund. Let’s walk through it. If you invest Rs.10,000 and the NAV is Rs.50, then you get 200 units (Rs.10,000 ÷ 50).
The fund declares a dividend of Rs.2 per unit, so with 200 units you get a total dividend payout of Rs.400 (200 × 2). At the same time, the NAV of the fund drops to Rs.48 (Rs.50 − Rs.2). The value of your current holding is now Rs.9,600 (Rs.48 × 200 units), and the cash received in your bank account is Rs.400.
There is no change in your total wealth because Rs.9,600 + Rs.400 = Rs.10,000. Essentially, the investment simply moves from one pocket (your mutual fund) to another (your bank account). This shows that the dividend is paid out from your investment value—it is not extra money.
If you’ve decided that getting regular cash is right for you, here are a few friendly tips for picking a fund:
You should not just chase the biggest payout, as a fund that promises a huge dividend might sometimes be struggling. A very high payout can be a sign that the fund’s NAV has dropped.
One should look for a steady track record where a fund that pays small but consistent dividends is often more reliable than one that’s all over the place.
Check the total return and don’t get fixated on the dividend rather look for the growth in the fund’s price plus the dividend.
Your goals come first, if you’re young and saving for the long haul, the Growth option is almost always your best friend as it lets your money work for you. IDCW plans are generally best for people who are retired and need cash for their expenses.
Conclusion
As we have read, we know that mutual funds pay dividends, which are now called IDCWs. The most important thing to remember is that this is not extra money. It’s just a part of your own investment being returned to you as cash. This is why the fund’s price (NAV) drops by the exact same amount.
Choosing between an IDCW plan (for cash payouts) and a Growth plan (to build wealth) is a personal decision. If you need regular income, IDCW can be useful. If you want your money to grow for the future, the Growth option is often the better path. The key is to understand how it works so you can make the best choice for your money.
S.NO.
Check Out These Interesting Posts You Might Enjoy!
Nope, they depend completely on whether the fund makes a profit and what the fund manager decides to do and they can be lowered or even stopped at any time.
How are these dividends taxed in India?
The IDCW you get is added to your total income for the year and taxed based on your income tax slab. If you receive more than Rs.5,000 from a single fund house in a year, they will also cut 10% tax (TDS) before you get your money.
Is a mutual fund dividend the same as a stock dividend from a company?
They’re different. A company dividend is a share of the company’s profits. A mutual fund’s IDCW is a mix of the fund’s earnings and can also include a part of your own invested capital. This is why the fund’s price (NAV) always drops by the exact dividend amount.
Can I get dividends every month?
Some funds do have plans that aim to pay out monthly. But even then, it’s not a promise as the fund needs to make enough profit to be able to share it.
What is meant by the “reinvestment” option?
Instead of getting cash, the dividend money is used to automatically buy more units of the fund for you. This is a great way to grow your investment, but remember, even though you don’t see the cash, it’s still considered income for that year and you’ll have to pay tax on it.
Canara Robeco Asset Management Company Limited, a leading mutual fund house jointly promoted by Canara Bank and ORIX Corporation of Japan, has launched its ₹1,326.13 crore Initial Public Offering (IPO), entirely as an Offer for Sale (OFS) (i.e., no fresh capital is being raised). The IPO opened for subscription on October 09, 2025, with a price band set between ₹253 and ₹266 per share. The subscription window will close on October 13, 2025, and the shares are scheduled to be listed on both the BSE and NSE on October 16, 2025.
Canara Robeco AMC IPO Day 3 Subscription Status
On Day 3, the Canara Robeco Asset Management Company IPO received a strong response from investors, closing with an overall subscription of 9.73 times. The Qualified Institutional Buyers (QIB) category led the demand with an impressive 25.92 times subscription, reflecting robust interest from institutional investors. The Non-Institutional Investors (NII) segment also saw healthy participation at 6.45 times, driven by both large and small high-net-worth investors. Within this category, the bNII (above ₹10 lakh) portion was subscribed 6.77 times, while the sNII (below ₹10 lakh) portion saw 5.79 times subscription. The Retail Individual Investors (RII) segment registered a decent response, subscribing 1.90 times, indicating steady interest from retail participants.
Investor Category
Subscription (x)
Qualified Institutional Buyers (QIB)
25.92
Non-Institutional Investors (NII)
6.45
bNII (above ₹10 lakh)
6.77
sNII (less than ₹10 lakh)
5.79
Retail Individual Investors (RII)
1.90
Total Subscriptions
9.73
Total Applications: 4,27,784
Total Bid Amount (₹ Crores): 9036
How to Check Canara Robeco Asset Management Co.Ltd IPO Allotment Status
Canara Robeco AMC allotment can be easily checked online in two ways: from the Registrar’s website and from the BSE or NSE website. This IPO will be listed on both the exchanges – BSE and NSE, so the allotment status will be available to all investors on both platforms.
Method 1: Registrar’s website (MUFG Intime India Pvt.Ltd.)
The most reliable way is to check allotment from MUFG Intime India Private Limited’s website.
How to do:
Visit MUFG Intime India Pvt.Ltd.’s official website
Select “Canara Robeco Asset Management ” from the IPO list
Enter your details PAN number, Application number, or DP/Client ID
Click on Submit
You will see the allotment status on the screen.
Method 2: Check from BSE or NSE’s website
If there is more traffic on the registrar’s website, allotment status can also be checked from BSE or NSE.
Select “Canara Robeco Asset Management ” from the IPO list
Enter PAN number and Application number
Click on Search
Objective of the Canara Robeco AMC
Canara Robeco Asset Management will not receive any proceeds from the Offer. All funds raised through the Offer will go entirely to the Selling Shareholder, after deduction of Offer-related expenses and applicable taxes, which will be borne solely by the Selling Shareholder.
Canara Robeco AMC GMP – Day 3 Update
The grey market premium (GMP) of Canara Robeco Asset Management Company Limited IPO stood at ₹9 as of 5:00 PM on October 13, 2025 (Day 3). Considering the upper end of the price band at ₹266, the estimated listing price is around ₹275, indicating a potential gain of approximately 3.38% per share.
Date
GMP
Est. Listing Price
Gain
13-10-2025 (Day 3)
₹9
₹275
3.38%
Disclaimer: The above GMP (Grey Market Premium) is just unofficial market information, which is not officially confirmed. These figures are shared for informational purposes only and investment decisions based on these should be based on the investor’s own research and discretion. We do not conduct, recommend or support any kind of transaction in the grey market.
Canara Robeco AMC – Key Details
Particulars
Details
IPO Opening Date
October 09, 2025
IPO Closing Date
October 13, 2025
Issue Price Band
₹253 to ₹266 per share
Total Issue Size
4,98,54,357 shares(aggregating up to ₹1,326.13 Cr)
Canara Robeco Asset Management Company Limited (Canara Robeco AMC), India’s second oldest asset management company, was incorporated in 1993 and became a joint venture between Canara Bank and ORIX Corporation Europe in 2007, with 51% and 49% shareholding respectively. The company offers a diversified portfolio across equity, debt, and hybrid schemes catering to both retail and institutional investors. As of June 30, 2025, it managed 26 mutual fund schemes with a Quarterly Average Assets Under Management (QAAUM) of ₹1,110.52 billion, reflecting a strong CAGR of 28.6% between FY23 and FY25.
Canara Robeco AMC has established itself as one of the fastest-growing fund houses in India, with retail investors contributing nearly 87% of its total AUM. The company has a significant presence in B-30 cities (beyond top 30 locations), contributing about 26% of its assets — among the highest in the industry. It leverages its strong parentage, experienced management, and a robust digital distribution network to strengthen market reach. With a focus on long-term wealth creation, prudent risk management, and governance standards, Canara Robeco AMC continues to build investor trust and maintain its position as one of India’s most reliable and consistent-performing mutual fund companies.
Frequently Asked Questions (FAQs)
What is the opening and closing date of Canara Robeco AMC?
Canara Robeco AMC is open on 09 October 2025 and will close on 13 October 2025.
What is the price band of the Canara Robeco AMC?
Its price band is fixed from ₹253 to ₹266 per share.
What is the GMP (Grey Market Premium) of Canara Robeco AMC today?
The GMP on 13 October 2025 is ₹9, which leads to a possible listing price of ₹275.
What is the total issue size of Canara Robeco AMC?
The total issue size of the Canara Robeco AMC is ₹1,326.13 crore, entirely as an “Offer for Sale”.
What is the expected listing date of Canara Robeco Asset Management ?
This IPO is expected to be listed on BSE and NSE on 16 October 2025.
Do you know many of the world’s biggest pharma companies don’t have their own drug manufacturing units for making their own medicines. These companies generally hire prominent drug manufacturing companies to make these essential drugs for them, this type of companies are called CDMO companies. India is becoming one of the world’s favourite manufacturers of medicines as per the global demands.
For investors it is a whole new and expanding area in the financial markets. In this blog we will talk about top CDMO companies in India, as these CDMO Pharma companies in India are getting a lot of attention from investors all over the world. Let’s dive into the top 10 CDMO stocks in India.
Top 10 CDMO Companies in India
Company Name
Current Market Price (Rs)
Market Capitalization (Cr)
52-Week High
52-Week Low
Divi’s Laboratories Ltd.
5,990
1,59,016
7,078
4,942
Cipla Ltd.
1,513
1,22,251
1,702
1,310
Dr. Reddy’s Labs Ltd.
1,256
1,04,786
1,406
1,020
Zydus Lifesciences Ltd.
984
98,988
1,072
795
Lupin Ltd.
1,925
87,926
2,403
1,774
Aurobindo Pharma Ltd.
1,085
63,563
1,530
994
Cohance Lifesciences Ltd.
875
33,492
1,360
856
Gland Pharma Ltd.
1,943
32,014
2,131
1,200
Syngene International Ltd.
634
25,526
961
599
Piramal Pharma Ltd.
196
25,993
308
180
(Data as of 07-10-2025)
Brief of Top 10 CDMO Companies in India
CDMO stands for Contract Development and Manufacturing Organization which acts as a one stop shop for pharmaceutical companies. Here are the top 10 CDMO companies in India.
1. Divi’s Laboratories Ltd.
Divi’s Laboratories Ltd. was founded in 1990 by Dr. Murali Krishna Prasad Divi, this company is one of the world’s trusted Active Pharmaceutical Ingredients (APIs) producers in India, APIs are the main ingredients of any medicine and Divi’s custom synthesis division is where they partner with world’s biggest pharma innovators to exclusively make their patented drug. The company is known for its quality, reliability and for expanding business as its new facility is being constructed in Kakinada. The company’s future seems unhindered and with time it can win more custom synthesis contracts making it more profitable.
2. Cipla Ltd.
Cipla Ltd. is a legendary name in the Indian Pharma sector, founded in 1935 by Dr. K.A. Hamied with a goal to make India self-reliant in the healthcare sector. The company is widely known for lung problem medicines and HIV medicines in the world also it has played a crucial role in AIDS treatment in Africa. This company sells its own branded medicines as well as it is in the CDMO space as well, focusing on specialised manufacturing. Cipla has a future fit growth strategy which includes boosting its presence in complex areas like peptides and biosimilars with the help of CDMO partnership.
3. Dr. Reddy’s Laboratories Ltd.
Dr. Reddy’s Laboratories Ltd. company founded by Dr. K.Anji Reddy in 1984, this company began by making APIs and rapidly transformed into a global pharma player. It is one of the Asian-pacific Pharma companies outside Japan which has been listed in the New York Stock Exchange since 2001. The company has a special CDMO business known as Aurigene Pharmaceuticals Services which caters globally. The company has a goal to reach 1.5 billion patients by 2030, also the company invests heavily in the R&D department of the company and plans to launch 25-30 new products in the next few years.
4. Zydus Lifesciences Ltd.
Zydus Lifesciences Ltd. Earlier known as Cadila Healthcare this company was founded way back in 1952 and has a long history in the pharmaceutical world. It is mostly known for making generic drugs and Zydus has recently started with the global biologics CDMO business. Biologics are complex, high-tech medicines like antibodies or vaccines which Zydus is manufacturing for its global clients. The company has bought two new manufacturing facilities in the United States giving it a major foothold in the US market which is the world’s biggest market for high-tech drugs. CDMO space can turn out to be a major growth engine for Zydus Lifesciences.
5. Lupin Ltd.
Dr. Desh Bandhu Gupta founded this company in 1968, it majorly started as manufacturer of anti-tuberculosis drugs and has since become one of the famous global giant and it also caters the US market. Lupin has two specialised CDMO divisions, one manufactures APIs and traditional drugs and the other one is for complex biologics. Lupin is now focused on R&D, large scale manufacturing as well as increasing its production. New complex generics like inhalers, and its entry in medicines like diabetes as well as weight loss drugs is increasing the revenue. Its CDMO business is a central part of its plan to offer high-value services.
6. Aurobindo Pharma Ltd.
Started in 1986 by Aurobindo Pharma is one of the major players in the generic drugs and APIs manufacturer with a wide spread presence over 125 countries. Aurobindo Pharma has recently purchased Lannett Company in the US giving the company a US based factory and a CDMO business that is specialised in controlled substances. This new development shows companies plan to grow in the US and build a powerful CDMO business.
7. Cohance Lifesciences Ltd.
This company has a history of specializing in the highly profitable area of medicines for the Central Nervous System (like the brain and spinal cord). The company was built specifically to be a focused CDMO player in the market, and with time it has made itself stronger through smart acquisitions. It is one of the key players in the CDMO sector after acquiring Cohance Lifesciences and Sapala Organics boosting its skills in antibody drug conjugates (ADCs) and oligonucleotides which are considered to be the future of medicines. Its plan is to focus on these niche, high-tech areas, expand its global sales team, and make more smart acquisitions to become a technology-driven CDMO powerhouse.
8. Gland Pharma Ltd.
Gland Pharma Ltd. was established in 1978 with specialization with injectable medicines, it mainly deals in B2B models. It is amongst the pioneers in India in setting up the country’s first USFDA approved facility for pre-filled syringes back in 2003. The company focuses on sterile injectables, cancer based drugs, and other complex medicines. The manufacturing record of Gland pharma and its long history of abiding by the USFDA and EMA are its key strengths. Gland is also expanding its operations by buying other companies like Cenexi Group to increase its global presence and add new skills.
9. Syngene International Ltd.
Syngene International Ltd. It is one of the major true DRDMOs (Contract Research, Development and Manufacturing Organization) which was started in 1993 as a part of Biocon. It has a good client base including global pharma giants like Bristol Myers Squibb and Amgen. The company deals in enhanced R&D, building new medicines, using advanced technology, computers and AI for faster and accurate results. The company is also expanding its manufacturing capacity by including a new facility in the US and getting even better at biologics and other next generation therapies. With a strong client base, analysts expect a continued growth over time.
10. Piramal Pharma Ltd.
Piramal Pharma has built a strong CDMO business in the pharmaceutical sector. It has a good presence in North America and European countries. It deals in cancer drugs and injectable medicines with focus on High Potency APIs (HPAPIs) services. It provides a holistic service of manufacturing and packaging medicines. The future growth potential of the company is based upon expanding its CDMO business as well as increasing its clients in US and Europe.
The “China Plus One” Strategy: The world has prominently relied heavily on manufacturing of medicines and essential drugs from, but due to global tensions companies are looking for an alternative reliable partner, so this strategy makes India as the top choice in the pharma world.
The BIOSECURE Act: The US is thinking to reduce their dependence on Chinese pharma companies and introduce a new BIOSECURE Act, by contracts straight to Indian CDMOs.
Cost and Quality Advantage: India has potential to give top quality R&D services and manufacturing capabilities at much lower costs.
Government Support: The Indian government’s Production Linked Incentive (PLI) scheme gives financial rewards to companies that boost the manufacturing of complex drugs in India.
Stricter Rules and Regulations: CDMO factories are regularly inspected by global health authorities like the USFDA. A bad inspection report or a “warning letter” can stop a company from selling its products in the US, which can seriously hurt its revenues and stock price.
High Competition: As the opportunity in the CDMO space grows, so does the competition. This could put pressure on quality, prices and profits in the long run.
Client Dependency: A CDMO’s success is tied to its clients’ success because if a client’s drug fails in clinical trials, the CDMO loses that project.
Constant Investment: CDMOs need to constantly invest in the latest technology and equipment to stay ahead of the competition, and this costs a lot of money.
CDMO companies are transforming from just being a supplier to becoming a key partner in global pharmaceutical innovation. With global demand and India’s capabilities to strengthen its R&D and manufacturing on its side, these companies can play a major role in the world. An investor shall always try to attain knowledge and then enter the market. Also the risks involved are the first step to making smart investment decisions.
S.NO.
Check Out These Interesting Posts You Might Enjoy!
Are regular pharma companies the same as CDMO stock?
Regular pharma companies growth depends upon their own branded drugs and a CDMO’s success totally depends upon getting contracts from different pharma companies.
What are the risks of CDMO stocks?
There are risks attached to CDMO stocks like regulators like USFDA and diverse investments like projects, pharma sector, R&D.
Why is the USFDA important for Indian companies?
The USA has high demand making it the most important and profitable market for Indian pharma companies, so getting most is the biggest and most profitable market for medicines in the world and USFDA allows these Indian companies to manufacture and sell drugs but a negative report can cut off the companies ties.
What does “China Plus One” mean for Indian CDMOs?
It’s a global trend where international companies are looking for a second manufacturing base outside of China to reduce their risks. India is seen as a potential base as it is less costly, skilled techniques and labours are available, and high quality products are made.
How can CDMO stocks be tracked?
One should follow the quarterly financial results of the companies mentioned in this blog. Also, keep an eye on news about USFDA inspections, announcements of big new contracts, and global trends in pharmaceutical outsourcing.
You already know why backtesting is so helpful if you’ve ever traded based on a “gut feeling” and then regretted it. It is like saying, “What if I had used this strategy before? Would it have worked?”
There has been significant progress in backtesting since 2025. AI, cloud platforms, and easy-to-use broker tools have made it possible for even regular traders like you to test strategies similar to hedge funds.
We will explain in this blog what backtesting is, why it is important, the tools you can use, and some examples you can try.
What is Backtesting
Think of backtesting as a time machine for traders. You come up with a strategy (say, “buy NIFTY when the 50-day moving average crosses above the 200-day moving average”), then you test it on old market data to see what would have happened.
It will not predict the future, but it gives you an idea of whether your strategy has potential or if it is just wishful thinking.
And here is the catch,
Backtesting helps in checking strategies on past data.
Paper trading/forward testing lets you use these strategies in real time without risking money.
Both matter. Backtesting shows you the past, and paper trading shows you how it handles today’s chaos.
Why Backtesting is Important
Markets today move faster than ever. AI bots, global events, etc., can shift things overnight. Below is why backtesting is useful.
Better data – You can get tick-by-tick history for stocks, forex, and crypto.
AI help – Platforms can optimise your settings automatically.
Cloud power – No need for a heavy-duty PC, cloud tools crunch years of data in minutes.
Easy access – Several online tools let you test ideas without writing a single line of code.
In short, backtesting keeps you from blindly trusting your gut. It tells you if your “great idea” has legs before you risk real money.
Here is the complete process, broken down into simple steps,
Write down your rules. Be clear in your mind. Example – Buy when RSI drops below 30 and price is above the 20-day EMA. Sell when RSI hits 70 or stop-loss of 5%.
Get the data. NSE/BSE feeds for stocks.
Pick your tool. Coders can use Python frameworks. If you do not like coding or do not belong to that background, you can also explore other options like TradingView.
Run the test. Apply your rules to past data and let the software do the work.
Check the results. Do not just look at profits; instead, dig into risk, drawdowns, and consistency.
Tweak carefully. Adjust parameters, but do not try to over-optimise
Validate in real time. Paper trade or test with a small amount of capital before going big.
Points to track during Backtesting
1. Win Rate
Simply put, how often your trades end up being winners. Example: If you win 6 out of 10 trades, that is a 60% win rate.
2. Risk-Reward Ratio
Are your profits bigger than your losses? For instance, if you risk ₹1 to make ₹2, that is a good and healthy 1:2 setup.
3. Profit Factor
This compares total profits to total losses. Anything above 1 means you are making more than you are losing (1.5 or higher is usually good).
4. Maximum Drawdown
The worst fall your account takes from peak to bottom. Helps you see how much pain you will need to sit through in a bad phase.
5. Sharpe or Sortino Ratio
These names might sound complex at first, but they show how much return you are getting for the risk you take. Higher is always better.
6. Out-of-Sample Testing
Test your idea on fresh data that it has not “seen” before. This shows whether your strategy is strong or simply lucky with past numbers.
Know what you are testing – Before diving in, be clear about your goal. Are you testing a trend-following strategy or something else? Having a focus keeps things simple and effective.
Use good data – Bad data leads to bad results. Make sure your historical price data is accurate and long enough to cover different market conditions. Do not forget things like stock splits, dividends, and other corporate actions.
Factor in real costs – Trading is not free! Include brokerage, slippage, and any other costs so your results reflect reality.
Test in different markets – A strategy that works in a bull market might fail in a bear market. Try it across various conditions, uptrends, downtrends, and sideways markets.
Do not over-optimise – It is tempting to tweak parameters to get perfect results, but too many changes can ruin your strategy in real life. Keep things realistic.
Keep it simple – Complex strategies may look impressive in backtests, but simple ones are easier to manage and more likely to survive in real markets.
Review and adapt – Markets change. Backtesting is not a one-and-done exercise. Keep checking and tweaking your strategies.
Example
The Idea – Think of this as a simple “trend-following” plan.
1. You buy when the 50-day moving average (MA) moves above the 200-day MA. That’s usually a sign the stock is gaining strength.
2. You sell when the 50-day MA dips below the 200-day MA, hinting the stock may be heading down.
Step 1 – Gather the Data
Pull daily price data for the stock from the last 5–10 years. Make sure it’s adjusted for things like stock splits and dividends so your numbers are accurate.
Step 2 – Apply the Rules
Calculate the 50-day and 200-day moving averages for each trading day.
1. Mark a buy when the 50-day crosses above the 200-day.
2. Mark a sell when it crosses below.
Step 3 – Testing
Suppose you started with ₹10,000.
1. On a buy signal, purchase the stock at the day’s closing price.
2. On the next sell signal, sell at that day’s close.
Also, do not forget to include brokerage costs and small slippages for a real-time picture.
Step 4 – Review the Results
Check how much profit or loss you’d end up with. Look at useful stats like max drawdown (how much you could have lost at worst), win/loss ratio, and risk-adjusted returns.
Finally, ask yourself, did the strategy work in trending markets but struggle in sideways ones? Were the losses reasonable compared to the gains? Could tweaking the rules make it better?
Backtesting is not about predicting the future; it is about being prepared. A good backtest helps you determine if your idea is worth pursuing, what risks to expect, and whether it aligns with your investment style. The best part is that tools are now easier to use, data will be richer, and AI is making the process smarter as well as easier. But no matter how fancy your software is, remember, discipline, forward testing, and risk management are what make strategies work in real life.
S.NO.
Check Out These Interesting Posts You Might Enjoy!
Simply choosing the right stock isn’t enough; how you buy and sell it matters just as much. Placing a large order all at once can often move the market price, leading to poor execution. To avoid this, traders rely on specialized execution strategies. Two of the most widely used are VWAP (Volume-Weighted Average Price) and TWAP (Time-Weighted Average Price). While VWAP executes trades in line with market volume, TWAP spreads orders evenly across fixed time intervals.
In this blog, we’ll break down what VWAP and TWAP are, their formulas, examples, their key differences, their role in different markets, common mistakes to avoid, and finally, how to choose the right approach for your trades.
What is VWAP?
VWAP, or Volume-Weighted Average Price, is an indicator that shows the average price of a stock during a trading day. However, this isn’t a simple average; each price is weighted by the volume at that time. This means that prices that are more heavily traded will have a greater impact on VWAP.
VWAP Formula
VWAP = ( Σ (Price × Volume) ) ÷ ( Σ Volume )
Where,
Price = the price of each trade
Volume = the number of shares bought/sold in that trade
Σ (Price × Volume) = the total of all trades (price × volume)
TWAP, or Time-Weighted Average Price, is an execution strategy in which a large order is divided into smaller parts and executed at equal intervals. The advantage of this is that it prevents sudden market pressure and allows the trade to be executed gradually. This method is often used when liquidity is low or the trader does not want their large order to be visible to the rest of the market.
TWAP Formula
TWAP = ( P₁ + P₂ + P₃ + … + Pₙ ) ÷ n
Where,
P₁, P₂, P₃ … Pₙ = prices traded at different times
n = total number of time intervals
Example: Suppose you need to buy 1,000 shares. You decide to split the order into 4 equal parts of 250 shares each and execute them at different times:
10 am – 250 shares at ₹200
11 am – 250 shares at ₹202
12 pm – 250 shares at ₹205
1 pm – 250 shares at ₹203
TWAP = (200 + 202 + 205 + 203) ÷ 4
= 810 ÷ 4
= ₹202.50
VWAP vs TWAP: Core Differences
Criteria
VWAP (Volume-Weighted Average Price)
TWAP (Time-Weighted Average Price)
Calculation Method
VWAP = ( Σ (Price × Volume) ) ÷ ( Σ Volume )
TWAP = ( P₁ + P₂ + P₃ + … + Pₙ ) ÷ n
Order Distribution Logic
Executes orders based on market volume
Order in equal parts at equal time intervals
Sensitivity to Volume
Highly sensitive where there is more volume, more orders will go there.
Independent of volume, based only on time
Best Suited Market
High liquidity stocks and indices
Assets with low liquidity or irregular volume
Pros
Orders blend with market trends, making benchmark comparison easier
Simple and predictable execution, low market impact
Cons
Sudden spikes in volume can distort VWAP, causing the executed price to deviate from the intended average.
TWAP executes orders at fixed intervals. If the market price moves unfavorably during an interval, the order for that interval will still be executed, which may result in a less-than-ideal price.
Best For Traders
Institutions and long-term investors with large orders
Options traders and those looking for steady execution in small tranches
When Should Traders Use VWAP?
VWAP is a simple strategy and is beneficial when the stock is liquid and the order is large. This ensures the order flows smoothly into the market without significantly impacting the price.
In liquid stocks : those with high daily volume VWAP integrates the order into market activity.
For institutions : Mutual funds and large investors compare their buying and selling with VWAP to see if execution occurs near the market average.
Reducing slippage : VWAP keeps the order close to the average price, preventing price distortion.
When orders are not urgent : If time permits, VWAP executes orders slowly and provides a better price.
When Should Traders Use TWAP?
TWAP is useful when market liquidity is low and the order is large. The order is divided into equal parts and executed at fixed time intervals. The advantage is that the trade is executed gradually and there is no sudden pressure on the price.
In low-liquidity stocks : where volume is low TWAP allows for order execution easily.
In crypto and forex markets : volume is uneven in these markets, so TWAP is more useful.
When not to signal the market : If you don’t want other traders to notice your large order, TWAP is the best option.
Widespread Use of VWAP in Equities : VWAP is most popular in the Indian equity market. This is because large-cap and liquid stocks have high daily volume. Therefore, VWAP smoothly integrates orders into the market flow, ensuring execution occurs around the average price. Mutual funds and institutional investors evaluate their trades using VWAP as a benchmark.
When is TWAP used? : TWAP is less common in equities, but it is used in low-liquidity stocks or block deals. TWAP divides orders evenly over time, preventing sudden price pressure. In Indian markets, it is often used when an investor does not want the market to signal a large order.
Trend of Hybrid Strategies : Many brokers and institutions are now using hybrid strategies by combining VWAP and TWAP. This makes execution more flexible. VWAP captures market volume, while TWAP provides time-based control. This approach is proving especially effective for large institutional desks.
Common Mistakes Traders Make with VWAP and TWAP
Universal Use : Many traders think that VWAP and TWAP are useful for every trade. The truth is that VWAP is good for liquid stocks, while TWAP is suitable for stocks or assets with low liquidity.
Ignoring Volume : VWAP operates on volume. If a stock has low volume and someone still executes a VWAP strategy, the execution will be inaccurate.
Not Considering Market Timing : TWAP executes at fixed intervals. If the market price is unfavorable at that time, the trade may be executed at a less-than-ideal price.
Blindly Following the Strategy : VWAP and TWAP are merely execution tools. If they are blindly followed without proper analysis and risk management, they can result in losses.
Both VWAP and TWAP offer unique advantages depending on the trading scenario. VWAP works best for liquid stocks and large institutional orders, while TWAP is ideal for low-liquidity situations or when gradual, steady execution is preferred. In the Indian equity market, VWAP is more widely used, but TWAP also plays a valuable role. Ultimately, the right strategy depends on the trader’s objectives, order size, and market conditions. Choosing the approach that aligns with your trade can help achieve smoother execution and better results. It is advised to consult a financial advisor before trading.
S.NO.
Check Out These Interesting Posts You Might Enjoy!
When most people think about buying stocks, the first thing that comes to mind is making profits by getting dividends, watching stock prices go up, and building wealth over time. But sometimes, being a shareholder comes with some extra perks. These benefits can include anything from free vouchers and early access to launches to discounts on goods and services. The company is saying “thank you” to its loyal shareholders by giving them these things. This is a common trend in Western markets, but a few Indian companies have also started giving these tempting bonuses.
Understanding Shareholder Perks
Shareholder perks are non-cash benefits given to investors in addition to traditional returns like dividends or stock price appreciation. These perks can include:
Discounts on hotel stays, restaurants, or retail products.
Gift vouchers for shopping or travel.
Priority access to new product launches.
Complimentary stays or services based on shareholding.
Globally, well-known companies like Disney have long offered perks, such as discounted park tickets, to their shareholders. Similarly, Berkshire Hathaway provides discounts at its owned businesses during its annual meetings. India has fewer examples, but the trend is slowly growing as companies feel that perks not only make investors happy but also strengthen customer loyalty.
Why Shareholder Perks Matter in India
In the last few years, the Indian stock market has seen a massive jump in the participation of retail investors. With several new demat accounts being opened every month, people are not just buying stocks as numbers on a screen anymore; they are buying into brands they actually use in their daily lives.
That is where shareholder perks come in. They do two simple things;
Bring investors closer to the brand – If you are both a customer and a shareholder, perks give you a more personal connection with the company.
Encourage long-term holding – Most perks come with minimum shareholding requirements, which means investors are motivated to stay invested.
List of Indian Companies Offering Shareholder Perks
1. ITC HOTELS
ITC goes beyond a big company; it is also one of the most popular names when it comes to shareholder perks. Through its hospitality arm, ITC Hotels, shareholders get access to discounts on stays, dining, and spa services. Eligible investors usually receive booklets or digital coupons that can be used at ITC’s luxury hotels and resorts. While these perks may not add up to huge savings compared to dividends, they offer a nice lifestyle benefit for anyone who enjoys premium experiences.
2. INDIAN HOTELS
Indian Hotels Company Limited (IHCL), which is part of the Tata Group and manages the famous Taj Hotels, gives its shareholders special perks like discounts on rooms, meals, and other luxury services at Taj properties. These benefits can help people who travel often or are Taj fans save a lot of money and feel more connected to the brand. It is not just about owning the stock, instead it is about getting a taste of the high-end Taj experience.
3. VIP INDUSTRIES
VIP Industries, India’s top luggage maker, has made its shareholders happy with product discounts. Investors have been offered savings on suitcases, bags, and accessories, perks, especially for families and travellers. Beyond the discounts, there is also the joy of using products from a company you partly own. By rewarding shareholders in this way, VIP Industries strengthens both customer loyalty and investor engagement.
4. TAJ GVK HOTELS & RESORTS
Taj GVK, a joint venture between Indian Hotels and the GVK Group, also offers perks to its shareholders. Investors can enjoy discounted room rates and services at Taj properties under its umbrella. The idea is simple: customers become shareholders, and shareholders become loyal customers. Taj GVK’s perks appeal strongly to those who value lifestyle-driven investments.
5. RAYMOND LIMITED
Raymond, the iconic textile and apparel brand, is famous for its premium fabrics, suits, and stylish clothing. Shareholders often enjoy special shopping discounts and vouchers, making it easier to pick up Raymond products at reduced prices. These perks not only add lifestyle value but also turn shareholders into natural ambassadors for the brand. For anyone who cares about fashion, it is the perfect blend of investment and everyday savings.
How to Find Companies’ Offerings Perks
If you are curious about shareholder perks, here are a few easy ways to track them down;
Annual Reports – Some companies include perks in their annual reports, but they usually do so in sections about governance or investor relations.
Investor Presentations – Brands in hospitality, retail, and other consumer spaces often talk about perks when trying to attract investors.
Investor Communities – Online forums and groups are great places to learn about benefits, requirements to join, and even real-life experiences from other investors.
Conclusion
Shareholder perks are not as common in India as they are in Western markets, but they are slowly becoming more popular. These benefits give investors more than just money. They make life better and make people feel like they are part of the brands they support.
That being said, you should not let the benefits be the only thing you think about when you invest. Long-term growth and strong fundamentals have to come first. If the perks fit with your lifestyle, think of them as a nice bonus along the way.
S.NO.
Check Out These Interesting Posts You Might Enjoy!
Biotechnology is now one of India’s most innovative and emerging industries. This sector offers an opportunity for creating wealth over time because there is a rising need for affordable medicines, vaccines, and innovative therapies.
In today’s blog post, we will give you an overview of the top biotech companies in India, along with the future of this sector.
What are Biotech Companies’ Stocks?
Biotech companies’ stocks are the shares of those companies which are primarily engaged in medicines, vaccines, etc. related to the healthcare sector. Through innovative technologies,they develop advanced medicines which are used to treat various diseases related to cancer, etc.
The overview of top biotech stocks to buy in India is as follows:
1. Biocon Limited
Kiran Mazumdar Shaw started Biocon Limited in 1978. It is now one of India’s top biopharmaceutical companies. The company started as a manufacturer of industrial enzymes and later transformed into a major player in the biopharmaceutical industry, focusing on new and affordable medicines. It has a strong presence across more than 120 countries. The company’s headquarters is situated in Bengaluru.
2. Anthem Biosciences Limited
The company was founded in 2006 by Ajay Bhardwaj, Ganesh Sambasivam, and K. Ravindra Chandrappa. The company started operations in 2007 with its Unit I facility at Bommasandra. It started with a 6 KL custom synthesis plant and later added a small fermentation capacity for discovery biology. Anthem Biosciences Limited is a well-known Indian Contract Research, Development, and Manufacturing Organisation (CRDMO). It has its headquarters in Bengaluru.
3. OneSource Speciality Pharma Limited
OneSource Speciality Pharma Limited is a biopharmaceutical CDMO (Contract Development & Manufacturing Organisation) with headquarters in Bengaluru, which offers comprehensive services for specialty pharmaceuticals and biologics. In June 2007, it was incorporated as Inbiopro Solutions Private Limited. In 2014, it changed its name to Stelis Biopharma Private Limited; in 2021, it went public; and in February 2024, it finally changed its name to Onesource Speciality Pharma Limited.
4. Sai Lifesciences Limited Company
The company was incorporated in 1999 and initially was named Sai Dru Syn Laboratories Limited. Later in 2012, the company finally changed its name to Sai Life Sciences Limited. The company merged with Prasad Drugs in 2004 and acquired Merrifield Pharma in 2006. It also has various R&D facilities in the USA and UK. Currently serves more than 250 global innovator pharma and biotech clients. The company’s headquarters is situated in Hyderabad.
5. Acutaas Chemicals Limited
The company was founded in 2004. Initially, it was a partnership firm, and later in 2007, it converted into a private limited company. Finally, in 2018, it became a publicly limited company. Recently, in 2025, the company changed its name to Acutaas Chemicals Limited. Acutaas has become increasingly significant in new fields, such as battery chemicals and semiconductor materials. This indicates that the company is dedicated to innovation. The company’s headquarters is situated in Gujarat.
6. Glaxosmithkline Pharma Limited
Glaxosmithkline Pharma Limited is generally known as GSK India. The company was incorporated in 1924, and initially it was named HJ Foster and Company Limited. In 1950, it changed its name to Glaxo Laboratories India Limited. Currently, it is one of the largest research-based pharma and healthcare companies. The vaccines offered by this company for immunisation like hepatitis A and B, influenza, chickenpox, etc. The company’s headquarters is situated in Mumbai.
7. Syngene International Limited
Syngene International Limited company was founded in 1993 and is promoted by Biocon and Kiran Mazumdar-Shaw. It became a subsidiary company of Biocon in 2002. Initially from CRDMO, it has started providing services in development, biologics, and clinical supplies etc. The company got itself listed in 2015. Its headquarters are situated in Bengaluru.
8. Indegene Limited
Indegene Limited company was founded in 1998 by entrepreneurs. The company commercialisation company that helps emerging biotech and biopharma companies and provides them with clinical products, marketing, technology, and its activation. They got major funding in 2021 from the private equity firm Carlyle Group and Brighton Park Capital. The company launched its IPO in 2024 and became a publicly listed company. Its headquarters are situated in Bengaluru.
9. Windlas Biotech Limited
Windlas Biotech Limited company was incorporated in 2001 by Ashok Kumar Windlass and started its first production plant in Dehradun. Later, it established various plants across the country, manufacturing tablets, capsules, etc. Along with the domestic clients, they also serve international clients. The company launched its IPO in 2021. The company’s headquarters is situated in Dehradun.
10. Vivo Biotech Limited
Vivo Biotech Limited was incorporated in 1987, and initially, it was named Sunshine Factors and Exports Limited. Later in 2002, the finally changed its name to Vivo Bio Tech Limited. Initially, the company focused on animal breeding and lab services. In 2010, the organisation achieved AAALAC International Accreditation. The company’s headquarters is situated in Hyderabad.
The key performance metrics of top biotech stocks are as follows:
Company
Debt to Equity
ROE (%)
ROCE (%)
Operating Profit Margin (%)
Net Profit Margin (%)
Biocon Limited
0.85
4.76
6.25
20.70
9.12
Anthem Biosciences Limited
0.05
20.80
28.50
36.40
24.46
Onesource Speciality Pharma Limited
0.13
3.34
5.52
33.10
7.26
Sai Lifesciences Limited
0.17
11.00
14.00
26.20
10.10
Acutaas Chemicals Limited
0
16.00
19.90
24.40
15.90
Glaxosmithkline Pharma Limited
0
46.90
63.20
32.00
23.30
Syngene International Limited
0.12
10.49
13.5
28.90
13.00
Indegene Limited
0.04
20.60
24.80
19.20
14.70
Windlas Biotech Limited
0.05
12.81
17.00
12.60
7.98
Vivo Biotech Limited
0.69
5.68
9.04
44.1
8.06
(As of 30th September, 2025)
Benefits of Investing in Biotech Stocks
The key benefits of investing in Biotech Stocks are as follows:
Innovative Industry: The biotech industry is based on constant new ideas in fields like genetics, cell therapy, biologics, and vaccines. This keeps the industry evolving while making it attractive for long-term investors.
Defensive Sector: The biotech and healthcare industries are considered defensive in nature, as medicines and healthcare services are essential even during economic downturns.
Government Support: Many governments provide incentives, subsidies, and favourable regulations to support biotech R&D, which increases growth prospects.
Factors to Consider Before Investing in Biotech Stocks
There are various factors which one should consider before investing in Biotech Stocks, a few of which are as follows:
Financial Performance: Before investing in Biotech stocks, one is required to consider the financial performance of the company and must invest in companies having higher profit margins.
Regulatory Approvals: Approval from regulatory bodies, including the US FDA, EMA, or CDSCO in India, is crucial for biotech companies. Any rejection from these regulatory bodies can significantly impact stock prices.
Management: The performance of biotech companies depends on the expertise of leadership. Hence, one should invest in companies with stable and experienced management.
The future looks promising for biotech stocks, thanks to rapid progress in genetics, biotechnology, and personalized healthcare. With rising global demand for better medical services, aging populations, and an increasing number of chronic illnesses, biotech companies are expected to play a key role in creating breakthrough therapies, vaccines, and diagnostics.
The industry in India is already valued at around ₹1,150 crore and is projected to grow nearly four times to about ₹4,000 crore by 2030. For investors, this growth story highlights biotech as one of the most exciting sectors to watch in the coming years.
Conclusion
On a concluding note, India’s biotechnology industry is shaping up as a hub of innovation, driven by strong R&D, growing healthcare needs, and supportive government policies. Leading biotech firms are not only creating new medicines and vaccines but also helping India emerge as a global center for affordable and advanced treatments.
That said, investing in biotech stocks isn’t without risks—clinical trials can fail, and regulatory approvals often take time. If you’re considering investing in this sector, it’s best to weigh the opportunities against the risks and consult a financial advisor before making a decision.
S.NO.
Check Out These Interesting Posts You Might Enjoy!
The top biotech stocks to invest in India are Biocon Limited, Anthem Biosciences Limited, OneSource Speciality Pharma Limited, Sai Lifesciences Limited Company, Acutaas Chemicals Limited, etc.
Is it safe to invest in biotech companies?
Yes, it is safe to invest in biotech companies, as this industry is considered defensive in nature, as the demand for healthcare-related products remains stable even during the economic downturn.
Is there any risk related to investing in biotech companies?
Yes, there are certain risks related to investing in biotech companies, such as regulatory approval by the authorities, trials by the companies, and technologies used by them.
Are biotech companies export-oriented?
Yes, most of the Indian biotech companies export the APIs (Active Pharmaceutical Ingredients) to various international companies.
Do the biotech companies declare dividends?
Yes, most of the biotech companies declare regular dividends; however, various companies reinvest the profit into their business research department. Therefore, before investing with an objective to get passive income from dividends from biotech companies, one should check the dividend yield of such companies.
Investors in India are no longer limited to just buying and selling stocks, but are also considering regular dividend income as an important strategy. In such a situation, it becomes important to have a reliable dividend tracker app India, which can easily manage your payouts, yield and records. Often investors track dividends manually and many times information is missed. In this blog, we will know about the best dividend investing app and best dividend yield app in India, which will help you understand and manage your passive income.
What is a Dividend Tracker App & Why You Need One
Dividend tracker app is a tool that automatically tracks dividend income from your stocks. Earlier, investors used to keep manual records by looking at excel sheets or broker statements, but now these apps show all the information in one place. It is not just an app to check the share price, but it also gives you a history of every dividend payment, ex-date, yield and an estimate of the expected dividend in future.
Difference from stock tracking app
General apps only show price, volume and market cap.
Dividend tracker app specifically provides information like dividend calendar, notifications and net payment calculation (amount after tax).
Benefits for investors
Auto tracking: As soon as a company declares a dividend or it is credited to your account, the app records it.
Reminders and alerts: Notifications of ex-dividend date and payment date are received on time.
Portfolio View: Shows your total dividend income and yield on a monthly, quarterly or yearly basis.
Passive Income Planning: By tracking income continuously, you can create a better financial strategy.
Best Dividend Tracker Apps in India
App Name
Dividend Updates & History
Features
Pocketful
Dividend calendar & payout records
Own broker platform, WhatsApp alerts for corporate actions (Dividends, Bonus, Split)
ET Money
Dividend history (MF + Stocks)
Dividend calendar, market news & updates
Moneycontrol
Dividend news & stock-wise history
Dividend calendar, market news & updates
Investing.com
Global + Indian dividend data & charts
Economic calendar, global market coverage
Tickertape
Dividend yield & past payout data
Advance screener, portfolio sync option
Trendlyne
Dividend history of 5–10 years
Forecast tools, analyst reports
BSE India
Official dividend announcements & records
Exchange verified corporate action data
NSE India
Dividend & corporate action records
Reliable official source for Indian market
1. Pocketful
Pocketful is a broker app that gives you a complete ecosystem of dividend tracking as well as trading. You can view information like dividend calendar, recent and past payouts, and record date directly in the app.
Pros:
It is a broker platform in itself. You don’t need separate apps for trading, demat, and dividend tracking.
Get corporate action alerts (like dividend, bonus, split, etc.) on WhatsApp, so you stay updated on time.
Linked to BSE, NSE, MCX, and SEBI so the data is quite reliable.
Cons :
Pocketful’s dividend analytics may not be as in-depth as the standalone tracking apps. But the advantage is that you don’t need to open a separate dividend app and all the information is in one place, saving both time and effort.
2. ET Money
ET Money is a comprehensive wealth-management app that tracks dividend history along with features like mutual funds, SIPs, loans, insurance, NPS.
Pros:
Can view dividend history of both mutual funds and stocks, with a particularly simple UI.
Adds more features like direct mutual funds, SmartDeposit, various tax-saving tools.
Can boost your returns with zero-commission direct funds.
Cons:
Dividend-specific graphs or yield forecasting are not as in-depth.
Alerts are in the form of educational newsletters or delayed updates, which can lead to a slight delay in taking timely action.
3. Moneycontrol
Moneycontrol is one of the most popular market apps in India—it shows dividend calendar, stock-specific dividend history and latest news.
Pros:
Dividend-news and payout calendar are updated regularly.
The interface is simple and self-explanatory—especially useful for new investors.
Having access to market news and dividend data from a single platform is a big advantage.
Cons:
No broker-integration or portfolio sync meaning you may find it easier to track data manually.
4. Investing.com
Investing.com is a trusted platform for investors not only in India but also around the world. If you also have international stocks in your portfolio, then this app is especially useful. It offers a dividend calendar, payout history and charts, which help you easily understand payout trends. Apart from this, corporate actions are also included in the economic calendar.
Pros:
Indian and global dividend data is available in one place.
Dividend history and charts are clean and easy to understand.
Diversified investors benefit from global coverage.
Cons:
There is no direct sync with Indian brokers.
Features like personalized portfolio view or tax reports are not available.
5. Tickertape
Tickertape is very popular among dividend-focused investors because it not only provides data but also in-depth analysis. Here you can see dividend yield and payout history, as well as easily identify high-yield stocks by applying dividend filter in the screener. If you want to create a dividend strategy in a systematic way, then Tickertape can prove to be very helpful.
Pros:
Shows dividend yield and payout history in detail.
Easy to find dividend-paying stocks with advanced screeners.
Portfolio sync (linked accounts) facility.
Cons:
There are no dedicated dividend alerts or reminders.
Lack of facilities like tax report or dividend-specific forecasting.
6. Trendlyne
Trendlyne is mainly known for research and analyst insights. In terms of dividend tracking, its biggest feature is its dividend history of 5 to 10 years. Apart from this, here you also get analyst ratings and forecasting tools, through which you can understand how sustainable the dividend of a company can be in the future.
Pros:
Dividend history is long and detailed (up to 5–10 years).
Deep understanding from forecasting tools and analyst coverage.
Corporate action alerts are received on time.
Cons:
There is no broker integration, data has to be viewed manually.
If you are a new investor, the interface may seem a bit complex.
7. BSE India
BSE India App is one of the most reliable sources for dividend data as the information comes directly from the exchange. Here you get dividend announcement, record date and payout history of every BSE-listed company. This is special for those investors who prefer accuracy.
Pros:
Verified data from the official exchange.
Company-wise dividend records and history are clearly available.
Corporate action updates with complete transparency.
Cons:
Lack of portfolio tracking or personalized view.
Only data of BSE-listed companies is available.
8. NSE India
NSE India App is the official platform of the National Stock Exchange and provides the most authentic information about dividend announcements or corporate actions. If you invest in NSE-listed stocks, then the information here is the most reliable and updated.
Pros:
Exchange-verified and reliable dividend data.
Dividend announcements, record dates and corporate actions available instantly.
No questions on accuracy as it is an official source.
Cons:
No features like portfolio or dividend history analysis.
Data limited to NSE-listed companies only.
Key Features to Look for in a Dividend Tracker App India
Real-time updates : A good dividend tracker app is useful only if it gives information immediately. As soon as a company declares a dividend or it is credited to your account, the app should show you a notification. This not only helps you keep track of payouts but also ensures that you do not miss the ex-dividend date.
Dividend history and yield record : It is important for an investor to know how a stock’s payout record has been. A reliable app will clearly show you all the previous dividend entries, payout ratio and yield history. Many apps also present it in the form of graphs and calendars, so that it is easy to understand the trend.
Insights and Graphical View : A dividend tracker should not just be limited to showing payouts. It should also show you a graph of dividend income on a monthly or yearly basis, give a sector-wise breakdown and provide useful insights like yield-on-cost.
Tax Reporting and Export Options : It is important to keep an accurate record of dividend income while filing ITR in India. This feature saves investors time and makes tax compliance easier.
Multi-asset support : Not just stocks, today many investors also hold ETFs, REITs and dividend-paying mutual funds. Therefore, a modern dividend tracker app should allow tracking payouts of all assets.
Accurate Corporate Action Tracking : In India, there is often a difference between the dates of dividend announcements and actual payments. In such a situation, it is important for the corporate action tracking of the app to be accurate, so that your records are completely accurate and reliable.
Don’t just run after high yield : Many times companies give a big dividend one year, but later reduce the payout. In such a situation, it is not right to invest just by looking at the high dividend yield. Always look at the payout consistency and the company’s earnings stability.
Make a Dividend Calendar : The biggest advantage of dividend tracker apps is that you can see your payouts month or quarter wise. With this, you can make a passive income calendar and plan your expenses or reinvestment better.
Keep diversification in sectors : If all your money is invested in a single sector (like IT or Oil & Gas), then your income will be affected as soon as the dividend policy changes. Diversification in different sectors reduces this risk.
Pay attention to Ex-Dividend Dates : You do not get a dividend on shares bought after the ex-dividend date. Therefore, while planning to buy, definitely check the ex-dividend dates shown in the apps.
Reinvest Dividends : If you want to build long-term wealth, reinvest dividends systematically instead of spending them. Many apps provide you with information or insights on dividend reinvestment, which makes your compounding faster.
Conclusion
Tracking dividends is not a difficult task, you just need the right tool. A good dividend tracker app India puts your payouts, record dates and history all in one place. This way there is no missing date or any calculation error. New investors can start with simple apps, while apps with more advanced features will help seasoned and serious investors more. Ultimately, the best app is the one that fits comfortably with your portfolio and investing habits.
S.NO.
Check Out These Interesting Posts You Might Enjoy!
